Aerospike’s New Expression Indexes Simplify Developer Code and Reduce Memory Overhead for Application and AI Queries 
Kangji Medical Receives Privatisation Proposal from a Consortium Led by Kangji Medical’s Chairman, Zhong Ming, TPG and QIA to Advance Long-Term Strategic Vision Centamin PLC Announces Q3 2021 Report
PERTH, AUSTRALIA / ACCESSWIRE / October 19, 2021 / Centamin plc (“Centamin”, “Group”or “the Company”)…
SolGold PLC Announces Cascabel Update: Tandayama-AmerĂca Maiden Resource
LONDON, UK / ACCESSWIRE / October 19, 2021 / The Board of Directors of SolGold…
Join the President of Colombia, Iván Duque, at this year’s Colombia Investment Summit
Bogotá, Columbia The hybrid event will showcase the country’s strategic advantages and exciting opportunities for…
Credenxia leaps into the future with Dock’s API
Preparing to move towards a decentralized solution for creating and managing employee credentials, Credenxia is…
Microsoft, Intel and Goldman Sachs to lead new TCG work group to tackle supply chain security challenges
Beaverton, OR, USA, October 19, 2021 – Trusted Computing Group (TCG) has today announced a…
Dataiku Honours Data Science Heroes
Everyday AI platform leader launches The History of Data Science, a definitive hub dedicated to…
BrightInsight Announces Appointment of Digital Biotech Veteran Meinhard F. Schmidt to Advisory Council
Schmidt Brings 25 Years of Executive Experience in Healthcare, Life Sciences, Diagnostics and Medical Devices…
Nicox Provides Third Quarter 2021 Business and Financial Highlights
Press Release Nicox Provides Third Quarter 2021 Business and Financial Highlights VYZULTA® and ZERVIATE® prescriptions…
Global Heart Hub and Novartis partner to tackle ASCVD, a global health crisis and world’s #1 killer
Invisible Nation is a worldwide network of patient organizations committed to driving a decline in…
Hyloris Announces Approval of Maxigesic® IV in the UK and Ireland
Maxigesic® IV provides a non-opioid, dual mode-of-action pain management alternative to traditional analgesics Liège, Belgium…
ObsEva Announces Presentation of Clinical Data on Oral GnRH Antagonist Linzagolix at ASRM 2021 Scientific Congress & Expo
–Presentation of Phase 3 clinical data on linzagolix for the treatment of uterine fibroids and…
Wave Life Sciences and Takeda Amend CNS Collaboration
Amendment to ongoing collaboration allows Wave to advance or partner CNS programs, including those using…
Harvard Bioscience Schedules Third Quarter 2021 Earnings Conference Call for November 3, 2021 at 8:00 AM ET
HOLLISTON, Mass., Oct. 18, 2021 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce…
OpGen Announces Closing of $15 Million Registered Direct Offering
ROCKVILLE, Md., Oct. 18, 2021 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen” or the…
Calithera Expands Oncology Pipeline with Acquisition of Two Clinical-Stage Assets from Takeda Pharmaceuticals
— TORC 1/2 inhibitor sapanisertib and SYK inhibitor mivavotinib strengthen Company’s precision oncology pipeline —…
Angion to Present Multiple Posters at Kidney Week 2021
UNIONDALE, N.Y., Oct. 18, 2021 (GLOBE NEWSWIRE) — Angion Biomedica Corp (NASDAQ:ANGN), a late-stage biopharmaceutical…
Paratek Pharmaceuticals Announces Enrollment of First Patient in Phase 2b Study Evaluating NUZYRA® (omadacycline) for Nontuberculous Mycobacterial (NTM) Pulmonary Disease Caused by Mycobacterium abscessus Complex (MABc)
— Potential $1 Billion Addressable Market Opportunity in the United States BOSTON, Oct. 18, 2021…
Entasis Therapeutics announces positive topline results for sulbactam-durlobactam (SUL-DUR) from Phase 3 ATTACK trial
SUL-DUR first to achieve statistical non-inferiority in 28-day all-cause mortality in carbapenem-resistant Acinetobacter (CRAB) patients…
Terns Pharmaceuticals to Present Positive Clinical Data on NASH Programs at AASLD The Liver Meeting® Digital Experience 2021
FOSTER CITY, Calif., Oct. 18, 2021 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the…
Iovance Biotherapeutics to Host Conference Call and Webcast to Highlight Data at Society for Immunotherapy of Cancer (SITC) Annual Meeting
Oral Presentation of Clinical Data for TIL in Combination with Pembrolizumabin Immune-Checkpoint Inhibitor NaĂŻve Patients…